Your browser doesn't support javascript.
loading
Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae.
Yang, Qin; Stevenson, Heather L; Scott, Melanie J; Ismail, Nahed.
Afiliación
  • Yang Q; Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Stevenson HL; Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Scott MJ; Department of Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Ismail N; Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: ismailn@upmc.edu.
Am J Pathol ; 185(2): 446-61, 2015 Feb.
Article en En | MEDLINE | ID: mdl-25481711

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interferón Tipo I / Lipopolisacáridos / Ehrlichiosis / Células TH1 / Ehrlichia / Inflamasomas / Inmunidad Celular Límite: Animals Idioma: En Revista: Am J Pathol Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interferón Tipo I / Lipopolisacáridos / Ehrlichiosis / Células TH1 / Ehrlichia / Inflamasomas / Inmunidad Celular Límite: Animals Idioma: En Revista: Am J Pathol Año: 2015 Tipo del documento: Article